You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR NORCURON


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for NORCURON

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00970762 ↗ Comparative Study of Rocuronium With Vecuronium (Study 71101)(COMPLETED) Completed Merck Sharp & Dohme Corp. Phase 3 2003-02-01 This study was conducted to determine and compare the safety and effectiveness of two neuromuscular blockers (rocuronium and vecuronium) at various doses in adults who are undergoing general elective surgery with sevoflurane anesthesia. Study participants received an intubating dose of a neuromuscular blocker (to enable insertion of a tube through the nose or mouth into the trachea to provide artificial ventilation). The intubating dose was followed by repeated bolus maintenance doses as needed, to maintain muscle relaxation. The time it takes to reach maximal effect of the neuromuscular blocker (onset time) after the intubating dose was measured and compared as the primary outcome.
NCT01690338 ↗ A Study of Residual Curarization Incidence in China Unknown status Central South University Phase 4 2012-10-01 The purpose of this study is to determine the incidence of residual curarization in PACU and relevant risk factors.
NCT01690338 ↗ A Study of Residual Curarization Incidence in China Unknown status China Medical University Hospital Phase 4 2012-10-01 The purpose of this study is to determine the incidence of residual curarization in PACU and relevant risk factors.
NCT01690338 ↗ A Study of Residual Curarization Incidence in China Unknown status Chinese PLA General Hospital Phase 4 2012-10-01 The purpose of this study is to determine the incidence of residual curarization in PACU and relevant risk factors.
NCT01690338 ↗ A Study of Residual Curarization Incidence in China Unknown status Eastern Hepatobiliary Surgery Hospital Phase 4 2012-10-01 The purpose of this study is to determine the incidence of residual curarization in PACU and relevant risk factors.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for NORCURON

Condition Name

Condition Name for NORCURON
Intervention Trials
Anesthesia 1
Inflammation 1
Perioperative/Postoperative Complications 1
PORC (Postoperative Residual Curarization) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for NORCURON
Intervention Trials
Inflammation 1
Postoperative Complications 1
Delayed Emergence from Anesthesia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for NORCURON

Trials by Country

Trials by Country for NORCURON
Location Trials
China 12
Slovenia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for NORCURON

Clinical Trial Phase

Clinical Trial Phase for NORCURON
Clinical Trial Phase Trials
Phase 4 1
Phase 3 1
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for NORCURON
Clinical Trial Phase Trials
Completed 2
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for NORCURON

Sponsor Name

Sponsor Name for NORCURON
Sponsor Trials
First Affiliated Hospital of Zhejiang University 1
Tianjin Medical University General Hospital 1
First Affiliated Hospital, Sun Yat-Sen University 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for NORCURON
Sponsor Trials
Other 24
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.